Back

Time-trends in the decision of a primary prevention strategy implementation in patients with hypertrophic cardiomyopathy

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 7 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Miguel Marques Antunes

Centro Hospitalar Universitario de Lisboa Central, E.P.E., Lisboa (Portugal)

7 More presentations in this session

Presentation thumbnail
Identification of a novel actin gene mutation, ACTC1 p.Asn94Ile, in a family with cardiomyopathy and conduction disease
Doctor R. Sepp (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Refining the diagnosis of hypertrophic cardiomyopathy with a machine learning-based radiomics model: a cardiovascular magnetic resonance study
Doctor I. Miranda (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Different exercise hemodynamic profiles in obstructive and nonobstructive hypertrophic cardiomyopathy: importance of unmasking diastolic dysfunction
Doctor C. Baratto (Bergamo, IT)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance feature tracking identifies preclinical abnormalities in hypertrophic cardiomyopathy sarcomere gene mutation carriers
Doctor F. Negri (Udine, IT)
Abstract Slides Video
Presentation thumbnail
Unraveling the complexity of hypertrophic cardiomyopathy: a machine learning-based radiomics model to predict phenotype and cardiovascular events
Doctor I. Miranda (Amadora, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial disease - clinical 7

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Predictors of implantable cardio-defibrillator activation in patients with hypertrophic cardiomyopathy at primary prevention of sudden cardiac death
thumbnail
Congress Presentation
Temporal trends in ICD prescription as primary prevention in non ischemic cardiomyopathy: 10 year single center registry
thumbnail
Congress Presentation
Cardiac magnetic resonance for prophylactic implantable-cardioVerter defibrillator therapy international registry in patients with ischemic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources